AstraZenecaGrant
AstraZeneca granted patent for 2,6,9-trisubstituted purines.
The filing
AstraZeneca was granted US patent 12790352 for 2,6,9-trisubstituted purines on November 10, 2026. The patent is titled "2,6,9-TRISUBSTITUTED PURINES" and can be viewed at 12790352 (opens in a new tab).
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.